Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 19 entries
Sorted by: Best Match Show Resources per page
Validation and Psychometric Evaluation of the Italian Version of the Bergen-Yale Sex Addiction Scale.

International journal of mental health and addiction

Soraci P, Melchiori FM, Del Fante E, Melchiori R, Guaitoli E, Lagattolla F, Parente G, Bonanno E, Norbiato L, Cimaglia R, Campedelli L, Abbiati FA, Ferrari A, Griffiths MD.
PMID: 34393683
Int J Ment Health Addict. 2021 Aug 09;1-27. doi: 10.1007/s11469-021-00597-w. Epub 2021 Aug 09.

Excessive problematic sexual behavior in the form of compulsive sexual behavior disorder (CSBD), hypersexuality (HS), and sex addiction has gained increasing credibility in recent years and has led to the development of various psychometric instruments to assess such behavior....

Cite
Soraci P, Melchiori FM, Del Fante E, et al. Validation and Psychometric Evaluation of the Italian Version of the Bergen-Yale Sex Addiction Scale. Int J Ment Health Addict. 2021;1-27doi: 10.1007/s11469-021-00597-w.
Soraci, P., Melchiori, F. M., Del Fante, E., Melchiori, R., Guaitoli, E., Lagattolla, F., Parente, G., Bonanno, E., Norbiato, L., Cimaglia, R., Campedelli, L., Abbiati, F. A., Ferrari, A., & Griffiths, M. D. (2021). Validation and Psychometric Evaluation of the Italian Version of the Bergen-Yale Sex Addiction Scale. International journal of mental health and addiction, 1-27. https://doi.org/10.1007/s11469-021-00597-w
Soraci, Paolo, et al. "Validation and Psychometric Evaluation of the Italian Version of the Bergen-Yale Sex Addiction Scale." International journal of mental health and addiction vol. (2021): 1-27. doi: https://doi.org/10.1007/s11469-021-00597-w
Soraci P, Melchiori FM, Del Fante E, Melchiori R, Guaitoli E, Lagattolla F, Parente G, Bonanno E, Norbiato L, Cimaglia R, Campedelli L, Abbiati FA, Ferrari A, Griffiths MD. Validation and Psychometric Evaluation of the Italian Version of the Bergen-Yale Sex Addiction Scale. Int J Ment Health Addict. 2021 Aug 09;1-27. doi: 10.1007/s11469-021-00597-w. Epub 2021 Aug 09. PMID: 34393683; PMCID: PMC8351585.
Copy Download .nbib Format: NLM
Influence of Research Continuity on Physician-Scientists' Career Success.

Neurology

Brownrout J, Norato G, Bensken W, Squirewell C, Gordon T, Heiss J, Nath A, Khan OI.
PMID: 34670817
Neurology. 2021 Nov 16;97(20):e2039-e2045. doi: 10.1212/WNL.0000000000012867. Epub 2021 Oct 20.

OBJECTIVE: To determine if maintaining continuity in research topic and method from early to late career yields a greater likelihood of physician-scientists' research career success; that is, achieving research independence and producing impactful publications.METHODS: To explore the effect of...

Cite
Brownrout J, Norato G, Bensken W, et al. Influence of Research Continuity on Physician-Scientists' Career Success. Neurology. 2021;97(20):e2039-e2045doi: 10.1212/WNL.0000000000012867.
Brownrout, J., Norato, G., Bensken, W., Squirewell, C., Gordon, T., Heiss, J., Nath, A., & Khan, O. I. (2021). Influence of Research Continuity on Physician-Scientists' Career Success. Neurology, 97(20), e2039-e2045. https://doi.org/10.1212/WNL.0000000000012867
Brownrout, Jenna, et al. "Influence of Research Continuity on Physician-Scientists' Career Success." Neurology vol. 97,20 (2021): e2039-e2045. doi: https://doi.org/10.1212/WNL.0000000000012867
Brownrout J, Norato G, Bensken W, Squirewell C, Gordon T, Heiss J, Nath A, Khan OI. Influence of Research Continuity on Physician-Scientists' Career Success. Neurology. 2021 Nov 16;97(20):e2039-e2045. doi: 10.1212/WNL.0000000000012867. Epub 2021 Oct 20. PMID: 34670817; PMCID: PMC8672432.
Copy Download .nbib Format: NLM
A Randomized Controlled Trial of SGS-742, a γ-aminobutyric acid B (GABA-B) Receptor Antagonist, for Succinic Semialdehyde Dehydrogenase Deficiency.

Journal of child neurology

Schreiber JM, Wiggs E, Cuento R, Norato G, Dustin IH, Rolinski R, Austermuehle A, Zhou X, Inati SK, Gibson KM, Pearl PL, Theodore WH.
PMID: 34015244
J Child Neurol. 2021 Nov;36(13):1189-1199. doi: 10.1177/08830738211012804. Epub 2021 May 20.

We examined safety, tolerability, and efficacy of SGS-742, a γ-aminobutyric acid B (GABA-B) receptor antagonist, in patients with succinic semialdehyde dehydrogenase deficiency. This was a single-center randomized, double-blind crossover phase II clinical trial of SGS-742 versus placebo in patients...

Cite
Schreiber JM, Wiggs E, Cuento R, et al. A Randomized Controlled Trial of SGS-742, a γ-aminobutyric acid B (GABA-B) Receptor Antagonist, for Succinic Semialdehyde Dehydrogenase Deficiency. J Child Neurol. 2021;36(13):1189-1199doi: 10.1177/08830738211012804.
Schreiber, J. M., Wiggs, E., Cuento, R., Norato, G., Dustin, I. H., Rolinski, R., Austermuehle, A., Zhou, X., Inati, S. K., Gibson, K. M., Pearl, P. L., & Theodore, W. H. (2021). A Randomized Controlled Trial of SGS-742, a γ-aminobutyric acid B (GABA-B) Receptor Antagonist, for Succinic Semialdehyde Dehydrogenase Deficiency. Journal of child neurology, 36(13), 1189-1199. https://doi.org/10.1177/08830738211012804
Schreiber, John M, et al. "A Randomized Controlled Trial of SGS-742, a γ-aminobutyric acid B (GABA-B) Receptor Antagonist, for Succinic Semialdehyde Dehydrogenase Deficiency." Journal of child neurology vol. 36,13 (2021): 1189-1199. doi: https://doi.org/10.1177/08830738211012804
Schreiber JM, Wiggs E, Cuento R, Norato G, Dustin IH, Rolinski R, Austermuehle A, Zhou X, Inati SK, Gibson KM, Pearl PL, Theodore WH. A Randomized Controlled Trial of SGS-742, a γ-aminobutyric acid B (GABA-B) Receptor Antagonist, for Succinic Semialdehyde Dehydrogenase Deficiency. J Child Neurol. 2021 Nov;36(13):1189-1199. doi: 10.1177/08830738211012804. Epub 2021 May 20. PMID: 34015244; PMCID: PMC8605041.
Copy Download .nbib Format: NLM
Giant axonal neuropathy: cross-sectional analysis of a large natural history cohort.

Brain : a journal of neurology

Bharucha-Goebel DX, Norato G, Saade D, Paredes E, Biancavilla V, Donkervoort S, Kaur R, Lehky T, Fink M, Armao D, Gray SJ, Waite M, Debs S, Averion G, Hu Y, Zein WM, Foley AR, Jain M, Bönnemann CG.
PMID: 34114613
Brain. 2021 Nov 29;144(10):3239-3250. doi: 10.1093/brain/awab179.

Giant axonal neuropathy (GAN) is an ultra-rare autosomal recessive, progressive neurodegenerative disease with early childhood onset that presents as a prominent sensorimotor neuropathy and commonly progresses to affect both the PNS and CNS. The disease is caused by biallelic...

Cite
Bharucha-Goebel DX, Norato G, Saade D, et al. Giant axonal neuropathy: cross-sectional analysis of a large natural history cohort. Brain. 2021;144(10):3239-3250doi: 10.1093/brain/awab179.
Bharucha-Goebel, D. X., Norato, G., Saade, D., Paredes, E., Biancavilla, V., Donkervoort, S., Kaur, R., Lehky, T., Fink, M., Armao, D., Gray, S. J., Waite, M., Debs, S., Averion, G., Hu, Y., Zein, W. M., Foley, A. R., Jain, M., & Bönnemann, C. G. (2021). Giant axonal neuropathy: cross-sectional analysis of a large natural history cohort. Brain : a journal of neurology, 144(10), 3239-3250. https://doi.org/10.1093/brain/awab179
Bharucha-Goebel, Diana X, et al. "Giant axonal neuropathy: cross-sectional analysis of a large natural history cohort." Brain : a journal of neurology vol. 144,10 (2021): 3239-3250. doi: https://doi.org/10.1093/brain/awab179
Bharucha-Goebel DX, Norato G, Saade D, Paredes E, Biancavilla V, Donkervoort S, Kaur R, Lehky T, Fink M, Armao D, Gray SJ, Waite M, Debs S, Averion G, Hu Y, Zein WM, Foley AR, Jain M, Bönnemann CG. Giant axonal neuropathy: cross-sectional analysis of a large natural history cohort. Brain. 2021 Nov 29;144(10):3239-3250. doi: 10.1093/brain/awab179. PMID: 34114613; PMCID: PMC8634068.
Copy Download .nbib Format: NLM
Respiratory magnetic resonance imaging biomarkers in Duchenne muscular dystrophy.

Annals of clinical and translational neurology

Mankodi A, Kovacs W, Norato G, Hsieh N, Bandettini WP, Bishop CA, Shimellis H, Newbould RD, Kim E, Fischbeck KH, Arai AE, Yao J.
PMID: 28904987
Ann Clin Transl Neurol. 2017 Jul 28;4(9):655-662. doi: 10.1002/acn3.440. eCollection 2017 Sep.

OBJECTIVE: To examine the diaphragm and chest wall dynamics with cine breathing magnetic resonance imaging (MRI) in ambulatory boys with Duchenne muscular dystrophy (DMD) without respiratory symptoms and controls.METHODS: In 11 DMD boys and 15 controls, cine MRI of...

Cite
Mankodi A, Kovacs W, Norato G, et al. Respiratory magnetic resonance imaging biomarkers in Duchenne muscular dystrophy. Ann Clin Transl Neurol. 2017;4(9):655-662doi: 10.1002/acn3.440.
Mankodi, A., Kovacs, W., Norato, G., Hsieh, N., Bandettini, W. P., Bishop, C. A., Shimellis, H., Newbould, R. D., Kim, E., Fischbeck, K. H., Arai, A. E., & Yao, J. (2017). Respiratory magnetic resonance imaging biomarkers in Duchenne muscular dystrophy. Annals of clinical and translational neurology, 4(9), 655-662. https://doi.org/10.1002/acn3.440
Mankodi, Ami, et al. "Respiratory magnetic resonance imaging biomarkers in Duchenne muscular dystrophy." Annals of clinical and translational neurology vol. 4,9 (2017): 655-662. doi: https://doi.org/10.1002/acn3.440
Mankodi A, Kovacs W, Norato G, Hsieh N, Bandettini WP, Bishop CA, Shimellis H, Newbould RD, Kim E, Fischbeck KH, Arai AE, Yao J. Respiratory magnetic resonance imaging biomarkers in Duchenne muscular dystrophy. Ann Clin Transl Neurol. 2017 Jul 28;4(9):655-662. doi: 10.1002/acn3.440. eCollection 2017 Sep. PMID: 28904987; PMCID: PMC5590523.
Copy Download .nbib Format: NLM
On the origin of internal field in Lithium Niobate crystals directly observed by digital holography.

Optics express

Paturzo M, Ferraro P, Grilli S, Alfieri D, De Natale P, de Angelis M, Finizio A, De Nicola S, Pierattini G, Caccavale F, Callejo D, Morbiato A.
PMID: 19498536
Opt Express. 2005 Jul 11;13(14):5416-23. doi: 10.1364/opex.13.005416.

We show the defect dependence of the internal field in Lithium Niobate using a full-field interferometric method and demonstrate that it can be directly measured on some clusters of defects embedded in a stoichiometric matrix. Results show that the...

Cite
Paturzo M, Ferraro P, Grilli S, et al. On the origin of internal field in Lithium Niobate crystals directly observed by digital holography. Opt Express. 2005;13(14):5416-23doi: 10.1364/opex.13.005416.
Paturzo, M., Ferraro, P., Grilli, S., Alfieri, D., De Natale, P., de Angelis, M., Finizio, A., De Nicola, S., Pierattini, G., Caccavale, F., Callejo, D., & Morbiato, A. (2005). On the origin of internal field in Lithium Niobate crystals directly observed by digital holography. Optics express, 13(14), 5416-23. https://doi.org/10.1364/opex.13.005416
Paturzo, Melania, et al. "On the origin of internal field in Lithium Niobate crystals directly observed by digital holography." Optics express vol. 13,14 (2005): 5416-23. doi: https://doi.org/10.1364/opex.13.005416
Paturzo M, Ferraro P, Grilli S, Alfieri D, De Natale P, de Angelis M, Finizio A, De Nicola S, Pierattini G, Caccavale F, Callejo D, Morbiato A. On the origin of internal field in Lithium Niobate crystals directly observed by digital holography. Opt Express. 2005 Jul 11;13(14):5416-23. doi: 10.1364/opex.13.005416. PMID: 19498536.
Copy Download .nbib Format: NLM
A Randomized Controlled Trial of SGS-742, a γ-aminobutyric acid B (GABA-B) Receptor Antagonist, for Succinic Semialdehyde Dehydrogenase Deficiency.

Journal of child neurology

Schreiber JM, Wiggs E, Cuento R, Norato G, Dustin IH, Rolinski R, Austermuehle A, Zhou X, Inati SK, Gibson KM, Pearl PL, Theodore WH.
PMID: 34015244
J Child Neurol. 2021 Nov;36(13):1189-1199. doi: 10.1177/08830738211012804. Epub 2021 May 20.

We examined safety, tolerability, and efficacy of SGS-742, a γ-aminobutyric acid B (GABA-B) receptor antagonist, in patients with succinic semialdehyde dehydrogenase deficiency. This was a single-center randomized, double-blind crossover phase II clinical trial of SGS-742 versus placebo in patients...

Cite
Schreiber JM, Wiggs E, Cuento R, et al. A Randomized Controlled Trial of SGS-742, a γ-aminobutyric acid B (GABA-B) Receptor Antagonist, for Succinic Semialdehyde Dehydrogenase Deficiency. J Child Neurol. 2021;36(13):1189-1199doi: 10.1177/08830738211012804.
Schreiber, J. M., Wiggs, E., Cuento, R., Norato, G., Dustin, I. H., Rolinski, R., Austermuehle, A., Zhou, X., Inati, S. K., Gibson, K. M., Pearl, P. L., & Theodore, W. H. (2021). A Randomized Controlled Trial of SGS-742, a γ-aminobutyric acid B (GABA-B) Receptor Antagonist, for Succinic Semialdehyde Dehydrogenase Deficiency. Journal of child neurology, 36(13), 1189-1199. https://doi.org/10.1177/08830738211012804
Schreiber, John M, et al. "A Randomized Controlled Trial of SGS-742, a γ-aminobutyric acid B (GABA-B) Receptor Antagonist, for Succinic Semialdehyde Dehydrogenase Deficiency." Journal of child neurology vol. 36,13 (2021): 1189-1199. doi: https://doi.org/10.1177/08830738211012804
Schreiber JM, Wiggs E, Cuento R, Norato G, Dustin IH, Rolinski R, Austermuehle A, Zhou X, Inati SK, Gibson KM, Pearl PL, Theodore WH. A Randomized Controlled Trial of SGS-742, a γ-aminobutyric acid B (GABA-B) Receptor Antagonist, for Succinic Semialdehyde Dehydrogenase Deficiency. J Child Neurol. 2021 Nov;36(13):1189-1199. doi: 10.1177/08830738211012804. Epub 2021 May 20. PMID: 34015244; PMCID: PMC8605041.
Copy Download .nbib Format: NLM
Influence of Research Continuity on Physician-Scientists' Career Success.

Neurology

Brownrout J, Norato G, Bensken W, Squirewell C, Gordon T, Heiss J, Nath A, Khan OI.
PMID: 34670817
Neurology. 2021 Nov 16;97(20):e2039-e2045. doi: 10.1212/WNL.0000000000012867. Epub 2021 Oct 20.

OBJECTIVE: To determine if maintaining continuity in research topic and method from early to late career yields a greater likelihood of physician-scientists' research career success; that is, achieving research independence and producing impactful publications.METHODS: To explore the effect of...

Cite
Brownrout J, Norato G, Bensken W, et al. Influence of Research Continuity on Physician-Scientists' Career Success. Neurology. 2021;97(20):e2039-e2045doi: 10.1212/WNL.0000000000012867.
Brownrout, J., Norato, G., Bensken, W., Squirewell, C., Gordon, T., Heiss, J., Nath, A., & Khan, O. I. (2021). Influence of Research Continuity on Physician-Scientists' Career Success. Neurology, 97(20), e2039-e2045. https://doi.org/10.1212/WNL.0000000000012867
Brownrout, Jenna, et al. "Influence of Research Continuity on Physician-Scientists' Career Success." Neurology vol. 97,20 (2021): e2039-e2045. doi: https://doi.org/10.1212/WNL.0000000000012867
Brownrout J, Norato G, Bensken W, Squirewell C, Gordon T, Heiss J, Nath A, Khan OI. Influence of Research Continuity on Physician-Scientists' Career Success. Neurology. 2021 Nov 16;97(20):e2039-e2045. doi: 10.1212/WNL.0000000000012867. Epub 2021 Oct 20. PMID: 34670817; PMCID: PMC8672432.
Copy Download .nbib Format: NLM
International retrospective natural history study of .

Brain communications

Ben Yaou R, Yun P, Dabaj I, Norato G, Donkervoort S, Xiong H, Nascimento A, Maggi L, Sarkozy A, Monges S, Bertoli M, Komaki H, Mayer M, Mercuri E, Zanoteli E, Castiglioni C, Marini-Bettolo C, D'Amico A, Deconinck N, Desguerre I, Erazo-Torricelli R, Gurgel-Giannetti J, Ishiyama A, Kleinsteuber KS, Lagrue E, Laugel V, Mercier S, Messina S, Politano L, Ryan MM, Sabouraud P, Schara U, Siciliano G, Vercelli L, Voit T, Yoon G, Alvarez R, Muntoni F, Pierson TM, Gómez-Andrés D, Reghan Foley A, Quijano-Roy S, Bönnemann CG, Bonne G.
PMID: 34240052
Brain Commun. 2021 Apr 11;3(3):fcab075. doi: 10.1093/braincomms/fcab075. eCollection 2021 Jul.

Muscular dystrophies due to heterozygous pathogenic variants in

Cite
Ben Yaou R, Yun P, Dabaj I, et al. International retrospective natural history study of . Brain Commun. 2021;3(3):fcab075doi: 10.1093/braincomms/fcab075.
Ben Yaou, R., Yun, P., Dabaj, I., Norato, G., Donkervoort, S., Xiong, H., Nascimento, A., Maggi, L., Sarkozy, A., Monges, S., Bertoli, M., Komaki, H., Mayer, M., Mercuri, E., Zanoteli, E., Castiglioni, C., Marini-Bettolo, C., D'Amico, A., Deconinck, N., Desguerre, I., Erazo-Torricelli, R., Gurgel-Giannetti, J., Ishiyama, A., Kleinsteuber, K. S., Lagrue, E., Laugel, V., Mercier, S., Messina, S., Politano, L., Ryan, M. M., Sabouraud, P., Schara, U., Siciliano, G., Vercelli, L., Voit, T., Yoon, G., Alvarez, R., Muntoni, F., Pierson, T. M., Gómez-Andrés, D., Reghan Foley, A., Quijano-Roy, S., Bönnemann, C. G., & Bonne, G. (2021). International retrospective natural history study of . Brain communications, 3(3), fcab075. https://doi.org/10.1093/braincomms/fcab075
Ben Yaou, Rabah, et al. "International retrospective natural history study of ." Brain communications vol. 3,3 (2021): fcab075. doi: https://doi.org/10.1093/braincomms/fcab075
Ben Yaou R, Yun P, Dabaj I, Norato G, Donkervoort S, Xiong H, Nascimento A, Maggi L, Sarkozy A, Monges S, Bertoli M, Komaki H, Mayer M, Mercuri E, Zanoteli E, Castiglioni C, Marini-Bettolo C, D'Amico A, Deconinck N, Desguerre I, Erazo-Torricelli R, Gurgel-Giannetti J, Ishiyama A, Kleinsteuber KS, Lagrue E, Laugel V, Mercier S, Messina S, Politano L, Ryan MM, Sabouraud P, Schara U, Siciliano G, Vercelli L, Voit T, Yoon G, Alvarez R, Muntoni F, Pierson TM, Gómez-Andrés D, Reghan Foley A, Quijano-Roy S, Bönnemann CG, Bonne G. International retrospective natural history study of . Brain Commun. 2021 Apr 11;3(3):fcab075. doi: 10.1093/braincomms/fcab075. eCollection 2021 Jul. PMID: 34240052; PMCID: PMC8260964.
Copy Download .nbib Format: NLM
A Randomized Controlled Trial of SGS-742, a γ-aminobutyric acid B (GABA-B) Receptor Antagonist, for Succinic Semialdehyde Dehydrogenase Deficiency.

Journal of child neurology

Schreiber JM, Wiggs E, Cuento R, Norato G, Dustin IH, Rolinski R, Austermuehle A, Zhou X, Inati SK, Gibson KM, Pearl PL, Theodore WH.
PMID: 34015244
J Child Neurol. 2021 Nov;36(13):1189-1199. doi: 10.1177/08830738211012804. Epub 2021 May 20.

We examined safety, tolerability, and efficacy of SGS-742, a γ-aminobutyric acid B (GABA-B) receptor antagonist, in patients with succinic semialdehyde dehydrogenase deficiency. This was a single-center randomized, double-blind crossover phase II clinical trial of SGS-742 versus placebo in patients...

Cite
Schreiber JM, Wiggs E, Cuento R, et al. A Randomized Controlled Trial of SGS-742, a γ-aminobutyric acid B (GABA-B) Receptor Antagonist, for Succinic Semialdehyde Dehydrogenase Deficiency. J Child Neurol. 2021;36(13):1189-1199doi: 10.1177/08830738211012804.
Schreiber, J. M., Wiggs, E., Cuento, R., Norato, G., Dustin, I. H., Rolinski, R., Austermuehle, A., Zhou, X., Inati, S. K., Gibson, K. M., Pearl, P. L., & Theodore, W. H. (2021). A Randomized Controlled Trial of SGS-742, a γ-aminobutyric acid B (GABA-B) Receptor Antagonist, for Succinic Semialdehyde Dehydrogenase Deficiency. Journal of child neurology, 36(13), 1189-1199. https://doi.org/10.1177/08830738211012804
Schreiber, John M, et al. "A Randomized Controlled Trial of SGS-742, a γ-aminobutyric acid B (GABA-B) Receptor Antagonist, for Succinic Semialdehyde Dehydrogenase Deficiency." Journal of child neurology vol. 36,13 (2021): 1189-1199. doi: https://doi.org/10.1177/08830738211012804
Schreiber JM, Wiggs E, Cuento R, Norato G, Dustin IH, Rolinski R, Austermuehle A, Zhou X, Inati SK, Gibson KM, Pearl PL, Theodore WH. A Randomized Controlled Trial of SGS-742, a γ-aminobutyric acid B (GABA-B) Receptor Antagonist, for Succinic Semialdehyde Dehydrogenase Deficiency. J Child Neurol. 2021 Nov;36(13):1189-1199. doi: 10.1177/08830738211012804. Epub 2021 May 20. PMID: 34015244; PMCID: PMC8605041.
Copy Download .nbib Format: NLM
Fluid-Attenuated Inversion Recovery Hyperintense Ischemic Stroke Predicts Less Favorable 90-Day Outcome after Intravenous Thrombolysis.

Cerebrovascular diseases (Basel, Switzerland)

Kim Y, Luby M, Burkett NS, Norato G, Leigh R, Wright CB, Kern KC, Hsia AW, Lynch JK, Adil MM, Latour LL.
PMID: 34284378
Cerebrovasc Dis. 2021;50(6):738-745. doi: 10.1159/000517241. Epub 2021 Jul 20.

INTRODUCTION: The absence of an ischemic lesion on MRI fluid-attenuated inversion recovery (FLAIR) is helpful in predicting stroke onset within 4.5 h. However, some ischemic strokes become visible on FLAIR within 4.5 h. We hypothesized that the early lesion...

Cite
Kim Y, Luby M, Burkett NS, et al. Fluid-Attenuated Inversion Recovery Hyperintense Ischemic Stroke Predicts Less Favorable 90-Day Outcome after Intravenous Thrombolysis. Cerebrovasc Dis. 2021;50(6):738-745doi: 10.1159/000517241.
Kim, Y., Luby, M., Burkett, N. S., Norato, G., Leigh, R., Wright, C. B., Kern, K. C., Hsia, A. W., Lynch, J. K., Adil, M. M., & Latour, L. L. (2021). Fluid-Attenuated Inversion Recovery Hyperintense Ischemic Stroke Predicts Less Favorable 90-Day Outcome after Intravenous Thrombolysis. Cerebrovascular diseases (Basel, Switzerland), 50(6), 738-745. https://doi.org/10.1159/000517241
Kim, Yongwoo, et al. "Fluid-Attenuated Inversion Recovery Hyperintense Ischemic Stroke Predicts Less Favorable 90-Day Outcome after Intravenous Thrombolysis." Cerebrovascular diseases (Basel, Switzerland) vol. 50,6 (2021): 738-745. doi: https://doi.org/10.1159/000517241
Kim Y, Luby M, Burkett NS, Norato G, Leigh R, Wright CB, Kern KC, Hsia AW, Lynch JK, Adil MM, Latour LL. Fluid-Attenuated Inversion Recovery Hyperintense Ischemic Stroke Predicts Less Favorable 90-Day Outcome after Intravenous Thrombolysis. Cerebrovasc Dis. 2021;50(6):738-745. doi: 10.1159/000517241. Epub 2021 Jul 20. PMID: 34284378; PMCID: PMC8639625.
Copy Download .nbib Format: NLM
Where Do Parkinson's Disease Patients Look while Walking?.

Movement disorders : official journal of the Movement Disorder Society

Vanegas-Arroyave N, Chen DF, Lauro PM, Norato G, Lungu C, Hallett M.
PMID: 34997620
Mov Disord. 2022 Jan 08; doi: 10.1002/mds.28917. Epub 2022 Jan 08.

BACKGROUND: Parkinson's disease (PD) is associated with gait and visuomotor abnormalities, but it is not clear where PD patients look during ambulation.OBJECTIVE: We sought to characterize the visual areas of interest explored by PD patients, with and without freezing...

Cite
Vanegas-Arroyave N, Chen DF, Lauro PM, et al. Where Do Parkinson's Disease Patients Look while Walking?. Mov Disord. 2022;doi: 10.1002/mds.28917.
Vanegas-Arroyave, N., Chen, D. F., Lauro, P. M., Norato, G., Lungu, C., & Hallett, M. (2022). Where Do Parkinson's Disease Patients Look while Walking?. Movement disorders : official journal of the Movement Disorder Society, . https://doi.org/10.1002/mds.28917
Vanegas-Arroyave, Nora, et al. "Where Do Parkinson's Disease Patients Look while Walking?." Movement disorders : official journal of the Movement Disorder Society vol. (2022). doi: https://doi.org/10.1002/mds.28917
Vanegas-Arroyave N, Chen DF, Lauro PM, Norato G, Lungu C, Hallett M. Where Do Parkinson's Disease Patients Look while Walking?. Mov Disord. 2022 Jan 08; doi: 10.1002/mds.28917. Epub 2022 Jan 08. PMID: 34997620.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 19 entries